The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized control study evaluating adjuvant metronomic chemotherapy in locally advanced head and neck cancers post-radical chemoradiation (MACE-CTRT).
 
Sunil Ramdhan Chopade
No Relationships to Disclose
 
Vijay Maruti Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Vanita Noronha
Research Funding - Amgen (Inst); AstraZeneca (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Nandini Sharrel Menon
No Relationships to Disclose
 
Atanu Bhattacharjee
No Relationships to Disclose
 
Kavita Prakash Nawale
No Relationships to Disclose
 
Shripad Dinanath Banavali
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)
 
Vijayalakshmi Mathrudev
No Relationships to Disclose